Finviz-Nachbau: Aktien-Screener
Aktien nach Sektor, Branche, Marktkapitalisierung, KGV und Performance filtern — im dichten Finviz-Tabellenlayout.
| Nr. | Ticker | Unternehmen | Sektor | Branche | Marktkap. (Mrd.) ▼ | KGV | Kurs ($) | Änd. % | Volumen |
|---|---|---|---|---|---|---|---|---|---|
| 21 | ADPT | Adaptive Biotechnologies Corp | Healthcare | Diagnostics & Research | 3,3 | — | 20,25 | +4,71% | 3.959.044 |
| 22 | GRAL | GRAIL, LLC | Healthcare | Diagnostics & Research | 2,9 | — | 66,57 | +3,08% | 598.518 |
| 23 | WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2,0 | — | 68,67 | +8,07% | 1.191.816 |
| 24 | NEO | NeoGenomics Inc | Healthcare | Diagnostics & Research | 1,8 | — | 13,73 | +6,43% | 4.309.385 |
| 25 | CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 1,5 | — | 27,85 | +2,65% | 1.315.840 |
| 26 | PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 1,3 | — | 12,59 | +10,83% | 4.941.256 |
| 27 | OPK | Opko Health Inc | Healthcare | Diagnostics & Research | 1,1 | — | 1,51 | +1,34% | 1.891.047 |
| 28 | CSTL | Castle Biosciences Inc | Healthcare | Diagnostics & Research | 0,7 | — | 22,91 | +3,57% | 305.329 |
| 29 | FLGT | Fulgent Genetics Inc | Healthcare | Diagnostics & Research | 0,5 | — | 19,44 | +1,62% | 244.745 |
| 30 | MYGN | Myriad Genetics Inc | Healthcare | Diagnostics & Research | 0,5 | — | 5,43 | +4,02% | 2.031.607 |
| 31 | IMDX | Insight Molecular Diagnostics Inc. | Healthcare | Diagnostics & Research | 0,2 | — | 5,59 | +3,90% | 153.512 |
| 32 | XGN | Exagen Inc | Healthcare | Diagnostics & Research | 0,1 | — | 4,64 | +2,65% | 181.214 |
| 33 | MDXH | MDxHealth SA ADR | Healthcare | Diagnostics & Research | 0,0 | — | 0,45 | -3,28% | 959.086 |